Covid treatment sotrovimab can cause drug-resistant mutation, study finds
by Melissa Davey Medical editor from on (#5WYQY)
Australian researchers raise concerns mutated virus could spread in the community if patients given the drug are not monitored
Australian virologists have uncovered a drug-resistant mutation in the Covid-19 virus associated with the drug sotrovimab and say without the monitoring of patients given the treatment the mutated virus could spread in the community.
The world-first findings, published in the New England Journal of Medicine on Thursday, are the result of an analysis of the first 100 patients in western Sydney during the Delta outbreak in 2021 to be given sotrovimab.
Sign up to receive an email with the top stories from Guardian Australia every morning
Continue reading...